Abstract
Kinetic analysis of vincristine (VCR) efflux in multidrug-resistant and parental P388 leukemia cells was performed to investigate the difference in activity between the two cell lines. Efflux velocities of VCR were directly determined from the slope of the initial release of drug induced by resuspending the preloaded cells in VCR-free medium, representing unidirectional efflux from intracellular free or loosely bound drug pools. Further, the equilibrium binding of VCR to whole-cell homogenates was analyzed by ultrafiltration to estimate intracellular unbound drug concentrations. A two-site binding model was found to fit the data best for both cell lines, and depletion of ATP by the addition of apyrase decreased binding. The binding parameters were similar between the two cell lines. A Hofstee plot of efflux demonstrated the existence of both linear and saturable transport of VCR in both cell lines. The greater maximum velocity observed with VCR efflux in the resistant cells suggests that an increased number of transporters causes greater activity of this process in the resistant cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
J. R. Bertino. Med. Pediat. Oncol. 5:105–114 (1978).
G. A. Curt, N. J. Clendenin, and B. A. Chabner. Cancer Treat. Rep. 68:87–99 (1984).
V. Ling, J. Gerlach, and N. Kartner. Breast Cancer Res. Treat. 4:89–99 (1984).
S. Kaye and S. Merry. Cancer Chemother. Pharmacol. 14:96–103 (1985).
R. K. Johnson, M. P. Chitnis, W. M. Embrey, and E. B. Gregory. Cancer Treat. Rep. 62:1535–1547 (1978).
K. Danø. Biochim. Biophys. Acta 323:1466–1483 (1973).
V. Ling and L. H. Thompson. J. Cell. Physiol. 83:103–116 (1973).
T. Skovsgaard. Cancer Res. 38:4722–4727 (1978).
M. Inaba, H. Kobayashi, Y. Sakurai, and R. K. Johnson. Cancer Res. 39:2200–2203 (1979).
M. Inaba and Y. Sakurai. Cancer Lett. 8:111–115 (1979).
W. T. Beck, M. C. Cirtain, and J. L. Lefko. Mol. Pharmacol. 24:485–492 (1983).
A. Fojo, M. Cornwell, C. Cardarelli, D. P. Clark, N. Richert, D.-W. Shen, K. Ueda, M. Willingham, M. M. Gottesman, and I. Pastan. Breast Cancer Res. Treat. 9:5–16 (1987).
P. Gros, Y. B. Neriah, J. M. Croop, and D. E. Housman. Nature (London) 323:728–731 (1986).
D.-W. Shen, A. Fojo, I. B. Roninson, J. E. Chin, R. Soffir, I. Pastan, and M. Gottesman. Mol. Cell. Biol. 6:4039–4055 (1986).
M. M. Cornwell, A. R. Safa, R. L. Felsted, M. M. Gottesman, and I. Pastan. Proc. Natl. Acad. Sci. USA 83:3847–3850 (1986).
A. R. Safa, C. J. Glover, M. B. Meyers, J. L. Biedler, and R. L. Felsted. J. Biol. Chem. 261:6137–6140 (1986).
C. Chen, J. E. Chin, K. Ueda, P. P. Clark, I. Pastan, M. M. Gottesman, and I. B. Roninson. Cell 47:381–389 (1986).
P. Gros, J. Croop, and D. Housman, Cell 47:371–380 (1986).
J. H. Gerlach, J. A. Endicott, P. F. Juranka, G. Henderson, F. Sarani, K. L. Deuchas, and V. Ling. Nature (London) 323:728–731 (1986).
M. Inaba, T. Watanabe, and Y. Sugiyama. Jpn. J. Cancer Res. (Gann) 78:397–404 (1987).
B. J. Houghton, P. J. Houghton, B. J. Hazelton, and E. C. Douglass. Cancer Res. 45:2706–2712 (1985).
K. Wierzba, Y. Sugiyama, T. Iga, and M. Hanano. J. Pharm. Dyn. 11:651–661 (1988).
P. E. Stanley and S. G. Williams. Anal. Biochem. 29:381–392 (1969).
K. Yamaoka, T. Nakagawa, and T. Uno. J. Pharmacokin. Biopharm. 6:165–175 (1978).
J. A. Houghton, L. G. Williams, R. K. Dodge, S. L. George, B. J. Hazelton, and P. J. Houghton. Biochem. Pharmacol. 36:81–88 (1987).
R. J. Owellen, A. H. Owens, Jr., and D. W. Donigian. Biochem. Biophys. Res. Commun. 47:685–691 (1972).
A. R. Safa, C. J. Glover, and R. L. Felsted. Cancer Res. 47:5149–5154 (1987).
M. Inaba, K. Nagashima, Y. Sakurai, M. Fukui, and Y. Yanagi. Gann 75:1049–1052 (1984).
M. Inaba and K. Nagashima. Jpn. J. Cancer Res. (Gann) 77:197–204 (1986).
M. Naito, H. Hamada, and T. Tsuruo. J. Biol. Chem. 263:11887–11891 (1988).
T. Tsuruo, H. Iida-Saito, H. Kawabata, T. Oh-hara, H. Hamada, and T. Utakoji. Jpn. J. Cancer Res. (Gann) 77:682–692 (1986).
D. D. Ross, J. V. Ordonez, C. C. Joneckis, J. R. Testa, and B. W. Thompson. Cytometry 9:359–367 (1988).
L. C. Bowman, J. A. Houghton, and P. J. Houghton. Biochem. Pharmacol. 37:1251–1257 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Watanabe, T., Inaba, M. & Sugiyama, Y. Saturable Process Involved in Active Efflux of Vincristine as a Mechanism of Multidrug Resistance in P388 Leukemia Cells. Pharm Res 6, 690–696 (1989). https://doi.org/10.1023/A:1015986405834
Issue Date:
DOI: https://doi.org/10.1023/A:1015986405834